| Date Filed | Type | Description |
| 06/08/2023 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 238,000 options to buy
@ $7.25, valued at
$1.7M
|
|
| 03/09/2023 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 331,114 options to buy
@ $1.46, valued at
$483.4k
|
|
| 03/09/2023 |
3
| Morris Richard Steven (CFO) has filed a Form 3 on Carisma Therapeutics Inc. |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 828 shares
@ $6.11, valued at
$5.1k
Granted 27,500 options to buy
@ $8.79, valued at
$241.7k
|
|
| 02/16/2016 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 27,500 options to buy
@ $8.58, valued at
$236k
|
|
| 02/18/2015 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 15,000 options to buy
@ $14.4, valued at
$216k
|
|
| 06/06/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2012 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Sold 5,300 shares
@ $33.01, valued at
$175k
Exercised 3,300 options to buy
@ $7.05, valued at
$23.3k
Exercised 2,000 options to buy
@ $5.91, valued at
$11.8k
|
|
| 01/06/2012 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 6,000 options to buy
@ $28.15, valued at
$168.9k
|
|
| 11/17/2011 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Sold 2,000 shares
@ $22.5903, valued at
$45.2k
Exercised 2,000 options to buy
@ $20.28, valued at
$40.6k
|
|
| 06/07/2011 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 6,000 options to buy
@ $17.98, valued at
$107.9k
|
|
| 01/07/2011 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 6,000 options to buy
@ $17.84, valued at
$107k
|
|
| 12/10/2010 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Sold 1,200 shares
@ $16.55, valued at
$19.9k
Sold 10,000 shares
@ $16.56, valued at
$165.6k
Sold 3,300 shares
@ $16.56, valued at
$54.6k
Exercised 1,200 options to buy
@ $3.55, valued at
$4.3k
Exercised 10,000 options to buy
@ $3.14, valued at
$31.4k
Exercised 3,300 options to buy
@ $3.55, valued at
$11.7k
|
|
| 06/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/08/2010 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 5,000 options to buy
@ $8.86, valued at
$44.3k
|
|
| 06/15/2009 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC |
| 01/12/2009 |
4
| Morris Richard Steven (Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC |